Alpha B-crystallin-a validated prognostic factor for poor prognosis in squamous cell carcinoma of the oral cavity

Acta Oto-Laryngologica

Volumn 134, Issue 5, 2014, Pages 543-550

  Annertz, Karin ^a   Enoksson, Jens ^a   Williams, Rebecca ^b   Jacobsson, Helene ^a   Coman, William B ^b   Wennerberg, Johan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

HNSCC; Oral cancer; Prognostic marker

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; OSTEONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TERTIARY CARE CENTER; TISSUE SECTION; CARCINOMA, SQUAMOUS CELL; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; PROGNOSIS; SWEDEN; VALIDATION STUDY;

AGED; ALPHA-CRYSTALLIN B CHAIN; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OSTEONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84897984592     PISSN: 00016489     EISSN: 16512251     Source Type: Journal    
DOI: 10.3109/00016489.2013.872293     Document Type: Article

References (13)

1. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
2. Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, et al. Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer 2009;45:1028-41.
3. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009;45:1042-66.
4. Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, et al. Novel markers for poor prognosis in head and neck cancer. Int J Cancer 2005;113:789-97. (Pubitemid 40101261)
5. Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, et al. Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope 2005;115:1239-42. (Pubitemid 40962362)
6. Boslooper K, King-Yin Lam A, Gao J, Weinstein S, Johnson N. The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma. Pathology 2008;40: 500-4. (Pubitemid 351950887)
7. Parcellier A, Schmitt E, Brunet M, Hammann A, Solary E, Garrido C. Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions. Antioxid Redox Signal 2005;7:404-13. (Pubitemid 40279808)
8. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A, et al. Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett 2007;581: 3665-74. (Pubitemid 47086314)
9. Pasini FS, Brentani MM, Kowalski LP, Federico MH. Transforming growth factor beta1, urokinase-type plas-minogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa. Head Neck 2001; 23:725-32. (Pubitemid 32751488)
10. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121:1813-20. (Pubitemid 47417302)
11. Liang XH, Lewis J, Foote R, Smith D, Kademani D. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 2008;66:1875-80.
12. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004;112:1015-19. (Pubitemid 39507008)
13. Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho OP, et al. Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000;83:614-19. (Pubitemid 30636302)